KPX Holdings Co., Ltd. Share Price

Equities

A092230

KR7092230002

Commodity Chemicals

End-of-day quote Korea S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
57,300 KRW +0.17% Intraday chart for KPX Holdings Co., Ltd. +3.24% +11.70%

Financials

Sales 2022 1,240B 902M 75.14B Sales 2023 1,207B 877M 73.11B Capitalization 202B 147M 12.22B
Net income 2022 8.91B 6.48M 540M Net income 2023 83.99B 61.06M 5.09B EV / Sales 2022 0.02 x
Net cash position 2022 190B 138M 11.5B Net cash position 2023 204B 148M 12.37B EV / Sales 2023 -
P/E ratio 2022
23.8 x
P/E ratio 2023
2.4 x
Employees 22
Yield 2022
5.56%
Yield 2023
6.82%
Free-Float 20.3%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.17%
1 week+3.24%
Current month-1.38%
1 month-1.55%
3 months+11.91%
6 months+14.14%
Current year+11.70%
More quotes
1 week
55 100.00
Extreme 55100
57 800.00
1 month
55 000.00
Extreme 55000
58 700.00
Current year
49 700.00
Extreme 49700
59 100.00
1 year
48 700.00
Extreme 48700
59 100.00
3 years
48 700.00
Extreme 48700
83 400.00
5 years
35 500.00
Extreme 35500
125 000.00
10 years
35 500.00
Extreme 35500
125 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 -
Chief Executive Officer 81 -
Comptroller/Controller/Auditor 51 -
Members of the board TitleAgeSince
Chief Executive Officer 81 -
Chief Executive Officer 55 -
Director/Board Member 55 -
More insiders
Date Price Change Volume
26/24/26 57,300 +0.17% 3,235
25/24/25 57,200 0.00% 1,754
24/24/24 57,200 +0.88% 2,147
23/24/23 56,700 +0.53% 923
22/24/22 56,400 +1.62% 1,047

End-of-day quote Korea S.E., April 26, 2024

More quotes
KPX HOLDINGS CO., LTD. is a Korea-based company holding company engaged in the management of its subsidiaries. The Company's main subsidiaries consist of KPX CHEMICAL Co.,Ltd, engaged in the manufacture of polypropylene glycol, urethane products and electronic materials; KPX GREEN CHEMICAL CO.,LTD, mainly engaged in the provision of ethoxylates (EOA) used as surfactants; KPX Life Science Co., Ltd., engaged in the manufacture and distribution of active pharmaceutical ingredients (API) and pharmaceutical intermediates (PI), as well as KPX DEVELOPMENT CO., LTD, engaged in the management and leasing of KPX buildings and others, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A092230 Stock